Waldencast plc (Nasdaq: WALD) announced that it has entered into a definitive agreement to sell its Obagi Medical dermatological skincare and aesthetics business to Bridgepoint, one of the world’s leading mid-market investors.
Latham & Watkins LLP represents Bridgepoint in the transaction with a corporate deal team led by New York partners Jane Greyf and David Allinson and Paris partner Olivier du Mottay, with associates Saïd Bakir, Meghan McDuff, and Anny Yang. Advice was provided on tax matters by New York partner Eric Kamerman, with associate Jacob Nagelberg; on intellectual property matters by New York partner Steven Betensky, with associate Alan Kim; and on benefits and compensation matters by Washington, D.C. partner Adam Kestenbaum, Washington, D.C. counsel Laura Szarmach, and London counsel Shaun Thompson, with associate Kevin Matheny.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.